Your browser doesn't support javascript.
loading
A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain.
Ramírez-García, Paulina D; Retamal, Jeffri S; Shenoy, Priyank; Imlach, Wendy; Sykes, Matthew; Truong, Nghia; Constandil, Luis; Pelissier, Teresa; Nowell, Cameron J; Khor, Song Y; Layani, Louis M; Lumb, Chris; Poole, Daniel P; Lieu, TinaMarie; Stewart, Gregory D; Mai, Quynh N; Jensen, Dane D; Latorre, Rocco; Scheff, Nicole N; Schmidt, Brian L; Quinn, John F; Whittaker, Michael R; Veldhuis, Nicholas A; Davis, Thomas P; Bunnett, Nigel W.
Afiliação
  • Ramírez-García PD; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Retamal JS; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, Victoria, Australia.
  • Shenoy P; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Imlach W; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, Victoria, Australia.
  • Sykes M; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Truong N; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, Victoria, Australia.
  • Constandil L; Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia.
  • Pelissier T; Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia.
  • Nowell CJ; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Khor SY; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, Victoria, Australia.
  • Layani LM; Laboratory of Neurobiology, Center for the Development of Nanoscience and Nanotechnology (CEDENNA), University of Santiago de Chile, Santiago, Chile.
  • Lumb C; Laboratory of Neurobiology, Center for the Development of Nanoscience and Nanotechnology (CEDENNA), University of Santiago de Chile, Santiago, Chile.
  • Poole DP; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Lieu T; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Stewart GD; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, Victoria, Australia.
  • Mai QN; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Jensen DD; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, Victoria, Australia.
  • Latorre R; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Scheff NN; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, Victoria, Australia.
  • Schmidt BL; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Quinn JF; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, Victoria, Australia.
  • Whittaker MR; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Veldhuis NA; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, Victoria, Australia.
  • Davis TP; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Bunnett NW; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Nat Nanotechnol ; 14(12): 1150-1159, 2019 12.
Article em En | MEDLINE | ID: mdl-31686009
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações de Ação Retardada / Nanopartículas / Dor Crônica / Antagonistas dos Receptores de Neurocinina-1 / Aprepitanto Limite: Animals / Humans / Male Idioma: En Revista: Nat Nanotechnol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações de Ação Retardada / Nanopartículas / Dor Crônica / Antagonistas dos Receptores de Neurocinina-1 / Aprepitanto Limite: Animals / Humans / Male Idioma: En Revista: Nat Nanotechnol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália